WallStSmart

OneSpan Inc (OSPN)vsZepp Health Corp (ZEPP)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Zepp Health Corp generates 6% more annual revenue ($258.90M vs $243.18M). OSPN leads profitability with a 30.0% profit margin vs -15.5%. OSPN earns a higher WallStSmart Score of 81/100 (A-).

OSPN

Exceptional Buy

81

out of 100

Grade: A-

Growth: 6.0Profit: 9.0Value: 9.3Quality: 5.0

ZEPP

Hold

41

out of 100

Grade: D

Growth: 4.7Profit: 2.0Value: 6.7Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

OSPNUndervalued (+63.9%)

Margin of Safety

+63.9%

Fair Value

$30.37

Current Price

$11.58

$18.79 discount

UndervaluedFair: $30.37Overvalued
ZEPPUndervalued (+48.6%)

Margin of Safety

+48.6%

Fair Value

$46.70

Current Price

$17.47

$29.23 discount

UndervaluedFair: $46.70Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

OSPN6 strengths · Avg: 9.3/10
P/E RatioValuation
6.1x10/10

Attractively priced relative to earnings

Return on EquityProfitability
30.1%10/10

Every $100 of equity generates 30 in profit

Profit MarginProfitability
30.0%10/10

Keeps 30 of every $100 in revenue as profit

EPS GrowthGrowth
57.4%10/10

Earnings expanding 57.4% YoY

PEG RatioValuation
0.798/10

Growing faster than its price suggests

Price/BookValuation
1.6x8/10

Reasonable price relative to book value

ZEPP2 strengths · Avg: 10.0/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
43.0%10/10

Revenue surging 43.0% year-over-year

Areas to Watch

OSPN2 concerns · Avg: 3.5/10
Revenue GrowthGrowth
2.9%4/10

2.9% revenue growth

Market CapQuality
$424.10M3/10

Smaller company, higher risk/reward

ZEPP4 concerns · Avg: 2.0/10
Market CapQuality
$247.54M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-17.2%2/10

ROE of -17.2% — below average capital efficiency

EPS GrowthGrowth
-68.1%2/10

Earnings declined 68.1%

Profit MarginProfitability
-15.5%1/10

Currently unprofitable

Comparative Analysis Report

WallStSmart Research

Bull Case : OSPN

The strongest argument for OSPN centers on P/E Ratio, Return on Equity, Profit Margin. Profitability is solid with margins at 30.0% and operating margin at 21.4%. PEG of 0.79 suggests the stock is reasonably priced for its growth.

Bull Case : ZEPP

The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.

Bear Case : OSPN

The primary concerns for OSPN are Revenue Growth, Market Cap.

Bear Case : ZEPP

The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.

Key Dynamics to Monitor

OSPN profiles as a value stock while ZEPP is a hypergrowth play — different risk/reward profiles.

ZEPP carries more volatility with a beta of 1.77 — expect wider price swings.

ZEPP is growing revenue faster at 43.0% — sustainability is the question.

Monitor SOFTWARE - INFRASTRUCTURE industry trends, competitive dynamics, and regulatory changes.

Bottom Line

OSPN scores higher overall (81/100 vs 41/100), backed by strong 30.0% margins. ZEPP offers better value entry with a 48.6% margin of safety. Both earn "Exceptional Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

OneSpan Inc

TECHNOLOGY · SOFTWARE - INFRASTRUCTURE · USA

OneSpan Inc. designs, develops and markets digital solutions for identity, security and business productivity globally. The company is headquartered in Chicago, Illinois.

Zepp Health Corp

TECHNOLOGY · CONSUMER ELECTRONICS · China

Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.

Want to dig deeper into these stocks?